(Axios) – A study of more than 2 million Veterans Health Administration patient records found GLP-1 drugs lowered the likelihood of dozens of health conditions including Alzheimer’s disease but also had some unexpected risks. Why it matters: The review in Nature Medicine provides some of the most compelling evidence yet that the blockbuster drugs for weight loss have widespread health benefits. (Read More)